Improved diagnostics and prognostics of lung cancer and metastases to the lungs
1 – 10 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
(
- Contribution to journal › Article
-
Mark
First-line Treatment Patterns and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden : A Population-based Real-world Study with Focus on Immunotherapy
(
- Contribution to journal › Article
-
Mark
3D cultivation of non-small-cell lung cancer cell lines using four different methods
(
- Contribution to journal › Article
-
Mark
Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
(
- Contribution to journal › Article
-
Mark
The impact of different fixatives on immunostaining of lung adenocarcinomas in pleural effusion cell blocks
2024) In Cancer Cytopathology(
- Contribution to journal › Article
- 2023
-
Mark
Reference standards for gene fusion molecular assays on cytological samples : an international validation study
(
- Contribution to journal › Article
-
Mark
Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma
(
- Contribution to journal › Article
-
Mark
Pulmonary 5-HT
2B receptor expression in fibrotic interstitial lung diseases.
(
- Contribution to journal › Article